BioStem Technologies, Inc. (BSEM)

8,56 -0,68 (-7,36%) Ab 11:22AM EDT. Markt geöffnet.

BioStem Technologies, Inc.

2836 Center Port Circle
Pompano Beach, FL 33064
United States
954 380 8342
https://www.biostemtechnologies.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Jason V. Matuszewski	CEO, President, Director & Secretary	N/A	N/A	N/A
Mr. Michael A. Fortunato CPA	Chief Financial Officer	N/A	N/A	N/A
Mr. Andrew Vanvurst	COO & Director	N/A	N/A	N/A
Dr. David M. Woynarowski	Chief Medical Officer	N/A	N/A	N/A
Mr. Larry Jones	Chief Revenue Officer	N/A	N/A	N/A
Dr. Irmgard Huber M.D.	International Medical Advisor & Interim Chief Medical Officer	N/A	N/A	N/A
Mr. Shawn F. McCarrey	Chief Commercial Officer	N/A	N/A	1958

Die Beträge haben den Stand und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

Corporate Governance

BioStem Technologies, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.